Annual report [Section 13 and 15(d), not S-K Item 405]

Related Party Transactions (Tables)

v3.25.1
Related Party Transactions (Tables)
12 Months Ended
Dec. 31, 2024
Related Party Transactions  
Schedule of PIK dividend or equity fee recorded

The following table summarizes, by subsidiary, the PIK dividends, annual equity fees, and equity fees recorded by the Company in accordance with the terms of the Founders Agreements, Exchange Agreements and the partner companies’/subsidiaries’ certificates of incorporation for the years ended December 31, 2024 and 2023 ($ in thousands):

PIK Dividend

Year Ended December 31, 

Partner company

    

Date

    

2024

    

2023

Avenue

January 1

410

444

Cellvation

 

October 31

 

10

 

10

Checkpoint

 

January 1

 

8,633

 

4,370

Cyprium

 

January 1

 

291

 

304

Helocyte

 

January 1

 

39

 

120

Mustang

 

January 1

 

940

 

591

Oncogenuity

 

May 8

 

9

 

9

Urica

November 25

514

502

Fortress

 

(10,846)

 

(6,350)

Total

$

$

Schedule of effective date and annual consulting fee payable by the subsidiary to the Company

The following table summarizes, by partner company/subsidiary, the effective date of the MSA and the annual consulting fee payable by the partner company/subsidiary to Fortress in quarterly installments ($ in thousands):

Year Ended December 31, 

Partner Company/Subsidiary

    

Effective Date

    

2024

2023

    

Avenue1

February 17, 2015

 

250

 

500

Cellvation

October 31, 2016

 

500

 

500

Checkpoint

March 17, 2015

 

500

 

500

Cyprium

March 13, 2017

 

500

 

500

Helocyte

March 20, 2015

500

500

Mustang

March 13, 2015

 

500

 

500

Oncogenuity

February 10, 2017

500

500

Urica

November 7, 2017

500

500

Fortress

 

(3,750)

 

(4,000)

Consolidated (Income)/Expense

$

$